Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2007

Open Access 01-12-2007 | Research article

Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity

Authors: Scarlett Lin Gomez, Cynthia D O'Malley, Antoinette Stroup, Sarah J Shema, William A Satariano

Published in: BMC Cancer | Issue 1/2007

Login to get access

Abstract

Background

Colorectal cancer, if detected early, has greater than 90% 5-year survival. However, survival has been shown to vary across racial/ethnic groups in the United States, despite the availability of early detection methods.

Methods

This study evaluated the joint effects of sociodemographic factors, tumor characteristics, census-based socioeconomic status (SES), treatment, and comorbidities on survival after colorectal cancer among and within racial/ethnic groups, using the SEER-Medicare database for patients diagnosed in 1992–1996, and followed through 1999.

Results

Unadjusted colorectal cancer-specific mortality rates were higher among Blacks and Hispanic males than whites (relative rates (95% confidence intervals) = 1.34 (1.26–1.42) and 1.16 (1.04–1.29), respectively), and lower among Japanese (0.78 (0.70–0.88)). These patterns were evident for all-cause mortality, although the magnitude of the disparity was larger for colorectal cancer mortality. Adjustment for stage accounted for the higher rate among Hispanic males and most of the lower rate among Japanese. Among Blacks, stage and SES accounted for about half of the higher rate relative to Whites, and within stage III colon and stages II/III rectal cancer, SES completely accounted for the small differentials in survival between Blacks and Whites. Comorbidity did not appear to explain the Black-White differentials in colorectal-specific nor all-cause mortality, beyond stage, and treatment (surgery, radiation, chemotherapy) explained a very small proportion of the Black-White difference. The fully-adjusted relative mortality rates comparing Blacks to Whites was 1.14 (1.09–1.20) for all-cause mortality and 1.21 (1.14–1.29) for colorectal cancer specific mortality. The sociodemographic, tumor, and treatment characteristics also had different impacts on mortality within racial/ethnic groups.

Conclusion

In this comprehensive analysis, race/ethnic-specific models revealed differential effects of covariates on survival after colorectal cancer within each group, suggesting that different strategies may be necessary to improve survival in each group. Among Blacks, half of the differential in survival after colorectal cancer was primarily attributable to stage and SES, but differences in survival between Blacks and Whites remain unexplained with the data available in this comprehensive, population-based, analysis.
Literature
1.
American Cancer Society: Cancer Facts and Figures 2007. 2007, Atlanta , American Cancer Society
2.
Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK: SEER Cancer Statistics Review, 1975-2004, based on November 2006 SEER data submission, posted to the SEER web site. Edited by: Institute NC. 2007, Bethesda, MD , [http://​seer.​cancer.​gov/​csr/​1975_​2004/​]
3.
Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LA: Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst. 1994, 86 (13): 997-1006. 10.1093/jnci/86.13.997.CrossRefPubMed
4.
Rabeneck L, El-Serag HB, Davila JA, Sandler RS: Outcomes of colorectal cancer in the United States: no change in survival (1986-1997). Am J Gastroenterol. 2003, 98 (2): 471-477.PubMed
5.
Chien C, Morimoto LM, Tom J, Li CI: Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005, 104 (3): 629-639. 10.1002/cncr.21204.CrossRefPubMed
6.
Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK: Cancer survival among US whites and minorities. Arch Intern Med. 2002, 162: 1985-1993. 10.1001/archinte.162.17.1985.CrossRefPubMed
7.
Cooper GS, Yuan Z, Rimm AA: Racial disparity in the incidence and case-fatality of colorectal cancer: analysis of 329 United States counties. Cancer Epidemiol Biomarkers Prev. 1997, 6 (4): 283-285.PubMed
8.
Hodgson DC, Fuchs CS, Ayanian JZ: Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst. 2001, 93 (7): 501-515. 10.1093/jnci/93.7.501.CrossRefPubMed
9.
Hodgson DC, Zhang W, Zaslavsky AM, Fuchs CS, Wright WE, Ayanian JZ: Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst. 2003, 95 (10): 708-716.CrossRefPubMed
10.
Lee-Feldstein A, Feldstein PJ, Buchmueller T: Health care factors related to stage at diagnosis and survival among Medicare patients with colorectal cancer. Med Care. 2002, 40 (5): 362-374. 10.1097/00005650-200205000-00002.CrossRefPubMed
11.
Mayberry RM, Coates RJ, Hill HA, Click LA, Chen VW, Austin DF, Redmond CK, Fenoglio-Preiser CM, Hunter CP, Haynes MA, et al: Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995, 87 (22): 1686-1693. 10.1093/jnci/87.22.1686.CrossRefPubMed
12.
Polednak AP: Poverty, comorbidity, and survival of colorectal cancer patients diagnosed in Connecticut. J Health Care Poor Underserved. 2001, 12 (3): 302-310.CrossRefPubMed
13.
Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Krischer JP: Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health. 2000, 90 (11): 1746-1754.CrossRefPubMedPubMedCentral
14.
Irby K, Anderson WF, Henson DE, Devesa SS: Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev. 2006, 15 (4): 792-797. 10.1158/1055-9965.EPI-05-0879.CrossRefPubMed
15.
Polite BN, Dignam JJ, Olopade OI: Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006, 24 (14): 2179-2187. 10.1200/JCO.2005.05.4775.CrossRefPubMed
16.
Marcella S, Miller JE: Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol. 2001, 54 (4): 359-366. 10.1016/S0895-4356(00)00316-4.CrossRefPubMed
17.
Choe JH, Koepsell TD, Heagerty PJ, Taylor VM: Colorectal cancer among Asians and Pacific Islanders in the U.S.: Survival disadvantage for the foreign-born. Cancer Detect Prev. 2005
18.
Gilliland FD, Hunt WC, Key CR: Trends in the survival of American Indian, Hispanic, and Non-Hispanic white cancer patients in New Mexico and Arizona, 1969-1994. Cancer. 1998, 82 (9): 1769-1783. 10.1002/(SICI)1097-0142(19980501)82:9<1784::AID-CNCR26>3.0.CO;2-#.CrossRefPubMed
19.
Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW, O'Malley CD: Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer. 2002, 94 (4): 1175-1182. 10.1002/cncr.10319.CrossRefPubMed
20.
Pagano IS, Morita SY, Dhakal S, Hundahl SA, Maskarinec G: Time dependent ethnic convergence in colorectal cancer survival in Hawaii. BMC Cancer. 2003, 3 (1): 5-10.1186/1471-2407-3-5.CrossRefPubMedPubMedCentral
21.
Schottenfeld D, Winawer SJ: Cancer of the large intestine. Cancer Epidemiology and Prevention. Edited by: Schottenfeld D, JF Fraumenia J. 1996, Oxford , Oxford University Press, 813-840.
22.
Whittemore AS, Wu-Williams AH, Lee M, Zheng S, Gallagher RP, Jiao DA, Zhou L, Wang XH, Chen K, Jung D, et al: Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst. 1990, 82 (11): 915-926. 10.1093/jnci/82.11.915.CrossRefPubMed
23.
Prehn A, Lin S, Clarke C, Packel L, Lum R, Lui S, Harper C, Lee M, Glaser S, West D: Cancer Incidence in Chinese, Japanese and Filipinos in the US and Asia 1988-1992. 1999, Union City, CA , Northern California Cancer Center
24.
Whittemore AS: Colorectal cancer incidence among Chinese in North America and the People's Republic of China: variation with sex, age and anatomical site. Int J Epidemiol. 1989, 18 (3): 563-568. 10.1093/ije/18.3.563.CrossRefPubMed
25.
Gomez SL, Glaser SL: Misclassification of race/ethnicity in a population-based cancer registry. Cancer Causes and Control. 2006, 17: 771-781. 10.1007/s10552-006-0013-y.CrossRefPubMed
26.
27.
Comstock RD, Castillo EM, Lindsay SP: Four-year review of the use of race and ethnicity in epidemiologic and public health research. Am J Epidemiol. 2004, 159 (6): 611-619. 10.1093/aje/kwh084.CrossRefPubMed
28.
Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993, 31 (8): 732-748. 10.1097/00005650-199308000-00006.CrossRefPubMed
29.
Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF: Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002, 40 (8 Suppl): IV-3-18..
30.
31.
Gomez SL, Le GM, West DW, Satariano WA, O'Connor L: Hospital policy and practice regarding the collection of data on race, ethnicity, and birthplace. Am J Public Health. 2003, 93 (10): 1685-1688.CrossRefPubMedPubMedCentral
32.
Polednak AP: Collecting information on race, Hispanic ethnicity, and birthplace of cancer patients: policies and practices in Connecticut hospitals. Ethn Dis. 2005, 15 (1): 90-96.PubMed
33.
Clegg LX, Reichman ME, Hankey BF, Miller BA, Lin YD, Johnson NJ, Schwartz SM, Bernstein L, Chen VW, Goodman MT, Gomez SL, Graff JJ, Lynch CF, Lin CC, Edwards BK: Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control. 2007
34.
Miller BA, Kolonel LN, Bernstein L, Young Jr JL, Swanson GM, West D, Key CR, Liff JM, Glover CS, Alexander GA, al. : Racial/Ethnic Patterns of Cancer in the United States, 1988-1992. 1996, Bethesda, MD , National Cancer Institute, NIH Pub. No. 96-4104:
35.
Kawachi I, Berkman LF: Neighborhoods and Health. 2003, New York , Oxford University PressCrossRef
36.
Krieger N, Chen JT, Waterman PD, Rehkopf DH, Yin R, Coull BA: Race/ethnicity and changing US socioeconomic gradients in breast cancer incidence: California and Massachusetts, 1978-2002 (United States). Cancer Causes Control. 2006, 17 (2): 217-226. 10.1007/s10552-005-0408-1.CrossRefPubMed
37.
Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W: Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006, 106 (6): 1276-1285. 10.1002/cncr.21732.CrossRefPubMed
38.
Singh GK, Miller BA, Hankey BF: Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part II--Lung and colorectal cancers. J Natl Cancer Inst. 2002, 94 (12): 916-925.CrossRefPubMed
39.
Singh GK, Miller BA, Hankey BF, Edwards BK: Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999. NCI Cancer Surveillance Monograph Series, Number 4 Bethesda, MD, National Cancer Institute. 2003
40.
Singh GK, Miller BA, Hankey BF, Edwards BK: Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004, 101 (5): 1051-1057. 10.1002/cncr.20467.CrossRefPubMed
41.
Singh GK, Miller BA, Hankey BF, Feuer EJ, Pickle LW: Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part I--All cancers among men. J Natl Cancer Inst. 2002, 94 (12): 904-915.CrossRefPubMed
42.
43.
Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R: Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002, 156 (5): 471-482. 10.1093/aje/kwf068.CrossRefPubMed
44.
Chandola T, Bartley M, Wiggins R, Schofield P: Social inequalities in health by individual and household measures of social position in a cohort of healthy people. J Epidemiol Community Health. 2003, 57 (1): 56-62. 10.1136/jech.57.1.56.CrossRefPubMedPubMedCentral
45.
46.
Diez Roux AV: The study of group-level factors in epidemiology: rethinking variables, study designs, and analytical approaches. Epidemiol Rev. 2004, 26: 104-111. 10.1093/epirev/mxh006.CrossRefPubMed
47.
Haan M, Kaplan GA, Camacho T: Poverty and health. Prospective evidence from the Alameda County Study. Am J Epidemiol. 1987, 125 (6): 989-998.PubMed
48.
Kubzansky LD, Subramanian SV, Kawachi I, Fay ME, Soobader MJ, Berkman LF: Neighborhood Contextual Influences on Depressive Symptoms in the Elderly. Am J Epidemiol. 2005
49.
Pickett KE, Pearl M: Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review. J Epidemiol Community Health. 2001, 55 (2): 111-122. 10.1136/jech.55.2.111.CrossRefPubMedPubMedCentral
50.
Robert SA: Socioeconomic position and health: the independent contribution of community socioeconomic context. Annual Review of Sociology. 1999, 25: 489-516. 10.1146/annurev.soc.25.1.489.CrossRef
51.
Robert SA, Strombom I, Trentham-Dietz A, Hampton JM, McElroy JA, Newcomb PA, Remington PL: Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology. 2004, 15 (4): 442-450. 10.1097/01.ede.0000129512.61698.03.CrossRefPubMed
52.
Subramanian SV: The relevance of multilevel statistical methods for identifying causal neighborhood effects. Soc Sci Med. 2004, 58 (10): 1961-1967. 10.1016/S0277-9536(03)00415-5.CrossRefPubMed
53.
Winkleby MA, Cubbin C: Influence of individual and neighbourhood socioeconomic status on mortality among black, Mexican-American, and white women and men in the United States. J Epidemiol Community Health. 2003, 57 (6): 444-452. 10.1136/jech.57.6.444.CrossRefPubMedPubMedCentral
54.
Yen IH, Kaplan GA: Neighborhood social environment and risk of death: multilevel evidence from the Alameda County Study. Am J Epidemiol. 1999, 149 (10): 898-907.CrossRefPubMed
55.
Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40 (5): 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed
56.
Klabunde CN, Warren JL, Legler JM: Assessing comorbidity using claims data: an overview. Med Care. 2002, 40 (8 Suppl): IV-26-35. 10.1097/00005650-200208001-00004.CrossRef
57.
Klabunde CN, Potosky AL, Legler JM, Warren JL: Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000, 53 (12): 1258-1267. 10.1016/S0895-4356(00)00256-0.CrossRefPubMed
58.
59.
Bach PB, Cramer LD, Warren JL, Begg CB: Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999, 341 (16): 1198-1205. 10.1056/NEJM199910143411606.CrossRefPubMed
60.
Cress RD, Zaslavsky AM, West DW, Wolf RE, Felter MC, Ayanian JZ: Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care. 2003, 41 (9): 1006-1012. 10.1097/01.MLR.0000083740.12949.88.CrossRefPubMed
61.
Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J: Studying radiation therapy using SEER-Medicare-linked data. Med Care. 2002, 40 (8 Suppl): IV-49-54. 10.1097/00005650-200208001-00007.CrossRef
62.
Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002, 40 (8 Suppl): IV-55-61.
63.
NIH consensus conference: Adjuvant therapy for patients with colon and rectal cancer. Jama. 1990, 264 (11): 1444-1450. 10.1001/jama.264.11.1444.CrossRef
64.
Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF: Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002, 20 (5): 1192-1202. 10.1200/JCO.20.5.1192.CrossRefPubMed
65.
Cronin DP, Harlan L, Potosky AL, Clegg LX, Stevens JL, Mooney MM: Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterology. 2006, 101: 2308-2318. 10.1111/j.1572-0241.2006.00775.x.CrossRef
66.
67.
68.
O'Malley CD, Le GM, Glaser SL, Shema SJ, West DW: Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study. Cancer. 2003, 97 (5): 1303-1311. 10.1002/cncr.11160.CrossRefPubMed
69.
Robbins AS, Koppie TM, Gomez SL, Parikh-Patel A, Mills PK: Differences in Prognostic Factors and Survival among White Men and Asian Men with Prostate Cancer, California, 1995-2004. Cancer.
70.
Robbins AS, Yin D, Parikh-Patel A: Differences in Prognostic Factors and Survival among White Men and Black Men with Prostate Cancer, California, 1995-2004. Am J Epidemiol. 2007, 166 (1): 71-78. 10.1093/aje/kwm052.CrossRefPubMed
71.
Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, Repelaer van Driel OJ, Coebergh JW: Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005, 92 (5): 615-623. 10.1002/bjs.4913.CrossRefPubMed
72.
Du XL, Meyer TE, Franzini L: Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer. 2007, 109 (11): 2161-2170. 10.1002/cncr.22664.CrossRefPubMed
73.
Dominitz JA, Samsa GP, Landsman P, Provenzale D: Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998, 82 (12): 2312-2320. 10.1002/(SICI)1097-0142(19980615)82:12<2312::AID-CNCR3>3.0.CO;2-U.CrossRefPubMed
74.
Akerley WL, Moritz TE, Ryan LS, Henderson WG, Zacharski LR: Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer. Arch Intern Med. 1993, 153 (14): 1681-1688. 10.1001/archinte.153.14.1681.CrossRefPubMed
75.
Shavers VL, Brown ML: Racial and ethnic disparities in the receipt of cancer treatment. Journal of the National Cancer Institute. 2002, 94 (5): 334-357.CrossRefPubMed
76.
Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L, Herrinton L, Quinn VP, Hart G, Hornbrook MC, Gurwitz JH, Wagner EH: Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007, 109 (3): 612-620. 10.1002/cncr.22437.CrossRefPubMed
77.
Baldwin LM, Dobie SA, Billingsley K, Cai Y, Wright GE, Dominitz JA, Barlow W, Warren JL, Taplin SH: Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005, 97 (16): 1211-1220.CrossRefPubMed
78.
Asian Pacific American Legal Center of Southern California, Asian Law Caucus, National Asian Pacific American Legal Consortium: The Diverse Face of Asians and Pacific Islanders in California. Asian & Pacific Islander Demographic Profile. 2005, Los Angeles, CA
79.
Lai H, Lai S, Krongrad A, Trapido E, Page JB, McCoy CB: The effect of marital status on survival in late-stage cancer patients: an analysis based on surveillance, epidemiology, and end results (SEER) data, in the United States. Int J Behav Med. 1999, 6 (2): 150-176. 10.1207/s15327558ijbm0602_4.CrossRefPubMed
80.
Lemmens VE, van Halteren AH, Janssen-Heijnen ML, Vreugdenhil G, Repelaer van Driel OJ, Coebergh JW: Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol. 2005, 16 (5): 767-772. 10.1093/annonc/mdi159.CrossRefPubMed
81.
82.
Babey SH, Ponce NA, Etzioni DA, Spencer BA, Brown ER, Chawla N: Cancer screening in California: racial and ethnic disparities persist. UCLA Center for Health Policy Research Policy Brief. 2003
83.
Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS: Racial and ethnic disparities in cancer screening. The importance of foreign birth as a barrier to care. J Gen Intern Med. 2003, 18: 1028-1035. 10.1111/j.1525-1497.2003.20807.x.CrossRefPubMedPubMedCentral
84.
Lee M: Breast and cervical cancer early detection in Chinese American women. Proceedings to Cancer Concerns for Asian Americans and Pacific Islanders (June 27-29, 1998, San Francisco, CA). Asian American and Pacific Islander Journal of Health. 1998, 6: 351-357.PubMed
85.
McBride MR, Pasick RJ, Stewart S, Tuason N, Sabogal F, Duenas G: Factors associated with cervical cancer screening among Filipino women in California. Proceedings to Cancer Concerns for Asian Americans and Pacific Islanders (June 27-29, 1998, San Francisco, CA). Asian American and Pacific Islander Journal of Health. 1998, 6: 358-367.PubMed
86.
McPhee SJ, Bird JA, Davis T, Ha NT, Jenkins CN, Le B: Barriers to breast and cervical cancer screening among Vietnamese-American women. Am J Prev Med. 1997, 13 (3): 205-213.PubMed
87.
McPhee SJ, Stewart S, Brock KC, Bird JA, Jenkins CN, Pham GQ: Factors associated with breast and cervical cancer screening practices among Vietnamese American women. Cancer Detect Prev. 1997, 21 (6): 510-521.PubMed
88.
Theisen C: In different cultures, cancer screening presents challenges. J Natl Cancer Inst. 2004, 96 (1): 10-12.CrossRefPubMed
89.
Gomez SL, Glaser SL, Kelsey JL, Lee MM, Sidney S: Inconsistencies between self-reported ethnicity and ethnicity recorded in a health maintenance organization. Annals of Epidemiology. 2005, 15: 71-79. 10.1016/j.annepidem.2004.03.002.CrossRefPubMed
90.
Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL: Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002, 40 (8 Suppl): IV-43-8. 10.1097/00005650-200208001-00006.CrossRef
91.
Cooper GS, Yuan Z, Stange KC, Dennis LK, Amini SB, Rimm AA: Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment. Med Care. 2000, 38 (4): 411-421. 10.1097/00005650-200004000-00008.CrossRefPubMed
92.
Warren JL, Harlan LC: Can cancer registry data be used to study cancer treatment?. Med Care. 2003, 41 (9): 1003-1005. 10.1097/01.MLR.0000086827.00805.B5.CrossRefPubMed
93.
Baldwin LM, Adamache W, Klabunde CN, Kenward K, Dahlman C, L. WJ: Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care. 2002, 40 (8 Suppl): IV-82-95.. 10.1097/00005650-200208001-00012.CrossRefPubMed
94.
Schrag D, Bach PB, Dahlman C, Warren JL: Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources. Med Care. 2002, 40 (8 Suppl): IV-96-103. 10.1097/00005650-200208001-00013.CrossRef
95.
Cooper GS, Koroukian SM: Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004, 100 (2): 418-424. 10.1002/cncr.20014.CrossRefPubMed
96.
Freeman JL, Klabunde CN, Schussler N, Warren JL, Virnig BA, Cooper GS: Measuring breast, colorectal, and prostate cancer screening with medicare claims data. Med Care. 2002, 40 (8 Suppl): IV-36-42. 10.1097/00005650-200208001-00005.CrossRef
97.
98.
Williams DR, Rucker TD: Understanding and addressing racial disparities in health care. Health Care Financ Rev. 2000, 21 (4): 75-90.PubMedPubMedCentral
99.
Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS: Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006, 24 (22): 3527-3534. 10.1200/JCO.2006.06.0855.CrossRefPubMed
100.
Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS: Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006, 24 (22): 3535-3541. 10.1200/JCO.2006.06.0863.CrossRefPubMed
101.
Porojnicu A, Robsahm TE, Berg JP, Moan J: Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol. 2007, 103 (3-5): 675-678. 10.1016/j.jsbmb.2006.12.031.CrossRefPubMed
102.
Robsahm TE, Tretli S, Dahlback A, Moan J: Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004, 15 (2): 149-158. 10.1023/B:CACO.0000019494.34403.09.CrossRefPubMed
103.
Grant WB: Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc. 2006, 98 (3): 357-364.PubMedPubMedCentral
104.
Glaser SL, Clarke CA, Gomez SL, O’Malley CD, Purdie DM, West DW: Cancer surveillance research: a vital subdiscipline of cancer epidemiology . Cancer Causes and Control. 2005, 16: 1009-1019. 10.1007/s10552-005-4501-2.CrossRefPubMed
Metadata
Title
Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity
Authors
Scarlett Lin Gomez
Cynthia D O'Malley
Antoinette Stroup
Sarah J Shema
William A Satariano
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2007
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-7-193

Other articles of this Issue 1/2007

BMC Cancer 1/2007 Go to the issue

Research article

Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials

Research article

A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

Research article

Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life

Study protocol

Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization – design and objectives of the Diagnosis Optimisation Study (DIOS)

Research article

Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases

Research article

A comparative study between mixed-type tumours from human salivary and canine mammary glands
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits